An acknowledgement of the first author’s funding from the National Human Genome Research Institute was omitted in this article by Naomi Scheinerman and Matthew McCoy (BMJ 2021;373:n1207;…
Raffle and Gill shine an uncomfortable light on a major strand of UK government policy—mass screening for asymptomatic SARS-CoV-2 infection.1 Presumably there are convincing counter arguments […]